{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T17:51:08Z","timestamp":1778089868094,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Department of Science & Technology, New Delhi","award":["SR\/FT\/LS-105\/2009"],"award-info":[{"award-number":["SR\/FT\/LS-105\/2009"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.cyto.2017.09.032","type":"journal-article","created":{"date-parts":[[2017,10,3]],"date-time":"2017-10-03T10:46:27Z","timestamp":1507027587000},"page":"65-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["TLR-induced secretion of novel cytokine IL-27 is defective in newly diagnosed type-2 diabetic subjects"],"prefix":"10.1016","volume":"104","author":[{"given":"Haridoss","family":"Madhumitha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viswanathan","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subash","family":"Babu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5639-4948","authenticated-orcid":false,"given":"Vivekanandhan","family":"Aravindhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2017.09.032_b0005","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.immuni.2011.05.006","article-title":"Toll-like receptors and their crosstalk with other innate receptors in infection and immunity","volume":"34","author":"Kawai","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2017.09.032_b0010","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.cyto.2015.02.025","article-title":"Toll-like receptors: Activation, signalling and transcriptional modulation","volume":"74","author":"De Nardo","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2017.09.032_b0015","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s12026-009-8113-x","article-title":"The contribution of direct TLR signaling to T cell responses","volume":"45","author":"Rahman","year":"2009","journal-title":"Immunol. Res."},{"key":"10.1016\/j.cyto.2017.09.032_b0020","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1073\/pnas.0400171101","article-title":"TLR2 is expressed on activated T cells as a costimulatory receptor","volume":"101","author":"Komai-Koma","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cyto.2017.09.032_b0025","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/ni1112","article-title":"Toll-like receptor control of the adaptive immune responses","volume":"5","author":"Iwasaki","year":"2004","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cyto.2017.09.032_b0030","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s10875-007-9137-4","article-title":"Aberrant expression of soluble co-stimulatory molecules and adhesion molecules in type 2 diabetic patients with nephropathy","volume":"28","author":"Wong","year":"2008","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.cyto.2017.09.032_b0035","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1681\/ASN.2013050518","article-title":"Role of podocyte B7\u20131 in diabetic nephropathy","volume":"25","author":"Fiorina","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cyto.2017.09.032_b0040","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.humimm.2011.08.015","article-title":"Toll-like receptors on the fork roads between innate and adaptive immunity","volume":"72","author":"Abdelsadik","year":"2011","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.cyto.2017.09.032_b0045","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nature04768","article-title":"Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4","volume":"441","author":"Gilchrist","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2017.09.032_b0050","doi-asserted-by":"crossref","first-page":"599","DOI":"10.15171\/apb.2015.081","article-title":"New Approaches to the Immunotherapy of Type 1 Diabetes Mellitus Using Interleukin-27","volume":"5","author":"Zamani","year":"2016","journal-title":"Adv. Pharm. Bull."},{"key":"10.1016\/j.cyto.2017.09.032_b0055","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.autrev.2015.08.001","article-title":"IL-27-induced modulation of autoimmunity and its therapeutic potential","volume":"14","author":"Meka","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.cyto.2017.09.032_b0060","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S1074-7613(02)00324-2","article-title":"IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells","volume":"16","author":"Pflanz","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2017.09.032_b0065","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.3390\/ijms16022851","article-title":"Interleukin-27 in T cell immunity","volume":"16","author":"Iwasaki","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cyto.2017.09.032_b0070","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.cyto.2008.02.014","article-title":"IL-12 serum levels in patients with type 2 diabetes treated with sulphonylureas","volume":"42","author":"Wegner","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2017.09.032_b0075","doi-asserted-by":"crossref","first-page":"718946","DOI":"10.1155\/2014\/718946","article-title":"Serum IL-17, IL-23, and TGF-beta levels in type 1 and type 2 diabetic patients and age-matched healthy controls","volume":"2014","author":"Roohi","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.cyto.2017.09.032_b0080","first-page":"1","article-title":"Levels of Interleukin 27 and Interleukin 35 in the Serum and Vitreous of Patients with Proliferative Diabetic Retinopathy","author":"Yan","year":"2016","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.cyto.2017.09.032_b0085","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/sj\/eye\/6700095","article-title":"Comparison of serum NO, TNF-alpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus","volume":"16","author":"Doganay","year":"2002","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.cyto.2017.09.032_b0090","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.cyto.2014.10.009","article-title":"Serum IL-9, IL-17, and TGF-beta levels in subjects with diabetic kidney disease (CURES-134)","volume":"72","author":"Vasanthakumar","year":"2014","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2017.09.032_b0095","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.cyto.2015.04.010","article-title":"Impaired toll-like receptor signalling in peripheral B cells from newly diagnosed type-2 diabetic subjects","volume":"76","author":"Madhumitha","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2017.09.032_b0100","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.coi.2007.10.010","article-title":"Antigen presentation by monocytes and monocyte-derived cells","volume":"20","author":"Randolph","year":"2008","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.cyto.2017.09.032_b0105","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/08830189009056630","article-title":"Dendritic cells as antigen presenting cells in vivo","volume":"6","author":"Inaba","year":"1990","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.cyto.2017.09.032_b0110","first-page":"17","article-title":"Dendritic cells: translating innate to adaptive immunity","volume":"311","author":"Steinman","year":"2006","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.cyto.2017.09.032_b0115","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cyto.2014.09.011","article-title":"T cell subsets and their signature cytokines in autoimmune and inflammatory diseases","volume":"74","author":"Raphael","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2017.09.032_b0120","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1084\/jem.190.8.1123","article-title":"In vivo-activated CD4 T cells upregulate CXC chemokine receptor 5 and reprogram their response to lymphoid chemokines","volume":"190","author":"Ansel","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2017.09.032_b0125","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S1074-7613(03)00300-5","article-title":"The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection","volume":"19","author":"Villarino","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2017.09.032_b0130","doi-asserted-by":"crossref","first-page":"8254797","DOI":"10.1155\/2016\/8254797","article-title":"Interleukin-22 Might Act as a Double-Edged Sword in Type 2 Diabetes and Coronary Artery Disease","volume":"2016","author":"Gong","year":"2016","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.cyto.2017.09.032_b0135","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1007\/s00018-008-8540-1","article-title":"The pathogenic role of interleukin-27 in autoimmune diabetes","volume":"65","author":"Wang","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.cyto.2017.09.032_b0140","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1016\/j.ajpath.2011.08.001","article-title":"IL-27 inhibits hyperglycemia and pancreatic islet inflammation induced by streptozotocin in mice","volume":"179","author":"Fujimoto","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cyto.2017.09.032_b0145","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/cei.12735","article-title":"Pathogenic T helper type 17 cells contribute to type 1 diabetes independently of interleukin-22","volume":"183","author":"Bellemore","year":"2015","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.cyto.2017.09.032_b0150","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1002\/eji.201344360","article-title":"Committed Tc17 cells are phenotypically and functionally resistant to the effects of IL-27","volume":"44","author":"El-Behi","year":"2014","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cyto.2017.09.032_b0155","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1089\/dia.2011.0182","article-title":"Increased levels of serum granulocyte-macrophage colony-stimulating factor is associated with activated peripheral dendritic cells in type 2 diabetes subjects (CURES-99)","volume":"14","author":"Surendar","year":"2011","journal-title":"Diabetes Technol. Ther."},{"key":"10.1016\/j.cyto.2017.09.032_b0160","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.diabres.2006.10.007","article-title":"Monocytes from type 2 diabetic patients have a pro-inflammatory profile. 1,25-Dihydroxyvitamin D(3) works as anti-inflammatory","volume":"77","author":"Giulietti","year":"2007","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.cyto.2017.09.032_b0165","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1084\/jem.150.2.246","article-title":"Ia determinants on stimulated human T lymphocytes. Occurrence on mitogen- and antigen-activated T cells","volume":"150","author":"Ko","year":"1979","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2017.09.032_b0170","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1365-2249.2006.03307.x","article-title":"Activated T cell subsets in human type 1 diabetes: evidence for expansion of the DR+ CD30+ subpopulation in new-onset disease","volume":"147","author":"Baker","year":"2007","journal-title":"Clin. Exp. Immunol."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466617302879?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466617302879?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T00:37:05Z","timestamp":1535330225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466617302879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":34,"alternative-id":["S1043466617302879"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2017.09.032","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TLR-induced secretion of novel cytokine IL-27 is defective in newly diagnosed type-2 diabetic subjects","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2017.09.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}